• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ALNA

ALNA

Allena Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.07

+0.00 (+3.16%)

Company Profile

CEO

Louis Brenner

IPO Date

2017-11-02

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.06

Prev. Close

$0.07

Day Low

$0.06

Day High

$0.15

Volume

252.31M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

21.6%

Avg Negative

27.3%

Avg Neutral

51.1%

News Feed

ALNA Stock Fell 35.04%: Why It Happened

Pulse2·7/15/2021·↓ negative

Allena Pharmaceuticals Announces $28 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

GlobeNewsWire·7/13/2021·↑ positive

Allena Pharmaceuticals, Inc. to Present at the Ladenburg Thalmann 2021 Virtual Healthcare Conference

GlobeNewsWire·7/8/2021·↑ positive

Allena Pharmaceuticals to Host Key Opinion Leader Webinar Focused on ALLN-346 for the Treatment of Gout in Patients with Chronic Kidney Disease

GlobeNewsWire·6/8/2021·↓ negative

Top Penny Stocks For Your May Watchlist? Check These 5 Out

PennyStocks·5/13/2021·↓ negative

Moving Average Crossover Alert: Allena Pharmaceuticals (ALNA)

Zacks Investment Research·5/12/2021·↓ negative

Allena Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewsWire·5/4/2021·↑ positive

Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

GlobeNewsWire·3/9/2021·↑ positive

Allena Pharmaceuticals to Present at Upcoming Investor Conferences in March

GlobeNewsWire·2/24/2021·↑ positive

Has Allena Pharmaceuticals (ALNA) Outpaced Other Medical Stocks This Year?

Zacks Investment Research·1/12/2021·↓ negative